Jennifer Fang is a partner in the Boston office of Wilson Sonsini Goodrich & Rosati PC. She helps innovative startups grow into successful enterprises by providing counsel to the founders, management teams and boards and by handling the legal and strategic business issues and transactions that arise at each stage. She is experienced in negotiating and executing a variety of corporate transactions, including conversions, spinouts, debt and equity financings, IPOs and other public offerings, PIPEs, mergers and acquisitions, and joint ventures. She also counsels venture capital, growth capital and strategic investors with respect to their investment transactions and their existing portfolio companies. Her practice focuses on companies that can improve patient lives and healthcare through innovations and advances, including in gene editing, cell therapy, novel therapeutics, synthetic biology, proteomics, diagnostics, bioinformatics, medical devices, and research and manufacturing tools and processes. Jennifer has been recognized by various publications and organizations for her work in the life sciences industry. She has been recognized in Chambers USA, which noted she is increasingly recognized for her work advising emerging life sciences companies on a wide range of corporate matters, including financings, IPOs, and M&A. Jennifer was also previously honored with the “Best Under 40” award by the National Asian Pacific American Bar Association (NAPABA), which highlighted her work with growing start-ups to enterprises. She was also awarded by Massachusetts Lawyers Weekly in as a “Top Woman of Law” and a "Go-To Business Lawyer." She is a member of the General Counsel Advisory Board to the National Venture Capital Association (NVCA) and member of the Advisory Board for the American Cancer Society (ACS) BrightEdge Entrepreneurs (BEE) program. In her free time, she enjoys mentoring young lawyers, entrepreneurs, and investors in the local community.